Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway (Q33456089)

26 July 2017

title

Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway (English)

1 reference

26 July 2017

1 reference

Ragnar K Breckan

1 reference

26 July 2017

Anne Mette Asfeldt

1 reference

26 July 2017

Bjørn Straume

1 reference

26 July 2017

Jon Florholmen

1 reference

26 July 2017

Eyvind J Paulssen

1 reference

26 July 2017

publication date

1 November 2012

1 reference

Scandinavian Journal of Gastroenterology

26 July 2017

published in

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

1274-1282

1 reference

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Societal costs for irritable bowel syndrome--a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Post-infectious irritable bowel syndrome: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Gastrointestinal infections and the development of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

IBS: An epigenetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Gene, environment, and brain-gut interactions in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Food intolerance in functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Gender and irritable bowel syndrome: the male connection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Natural history of functional dyspepsia: a 10-year population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Functional dyspepsia impairs quality of life in the adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Migraine, fibromyalgia, and depression among people with IBS: a prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Prevalence of irritable bowel syndrome and its relationship with Helicobacter pylori infection in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Towards a true prevalence of peptic ulcer: the Sørreisa gastrointestinal disorder study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in Northern Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

An Irritable Bowel Syndrome-Specific Symptom Questionnaire: Development and Validation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Prevalence, comorbidity and impact of irritable bowel syndrome in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

An update on irritable bowel syndrome: from diagnosis to emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Clinical practice. Irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Diagnosing Irritable Bowel Syndrome: A Changing Clinical Paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Reporting participation in epidemiologic studies: a survey of practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Diagnosis, Comorbidities, and Management of Irritable Bowel Syndrome in Patients in a Large Health Maintenance Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.688215

10.3109/00365521.2012.688215

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference